GAYONG SHIM ET AL: "Application of cationic liposomes for delivery of nucleic acids", ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 8, no. 2, 1 April 2013 (2013-04-01), pages 72-80, XP055198336, ISSN: 1818-0876, DOI: 10.1016/j.ajps.2013.07.009 (B1)

WO-A1-2013/053775 (B1)

IGNACIO MELERO ET AL: "Evolving synergistic combinations of targeted immunotherapies to combat cancer", NATURE REVIEWS. CANCER, vol. 15, no. 8, 24 July 2015 (2015-07-24), pages 457-472, XP055316136, GB ISSN: 1474-175X, DOI: 10.1038/nrc3973 (B1)

ISMAIL M. MERAZ ET AL: "Adjuvant Cationic Liposomes Presenting MPL and IL-12 Induce Cell Death, Suppress Tumor Growth, and Alter the Cellular Phenotype of Tumors in a Murine Model of Breast Cancer", MOLECULAR PHARMACEUTICS, vol. 11, no. 10, 6 October 2014 (2014-10-06), pages 3484-3491, XP055388647, US ISSN: 1543-8384, DOI: 10.1021/mp5002697 (B1)

JONATHAN M WEISS ET AL: "Immunotherapy of cancer by IL-12-based cytokine combinations", EXPERT OPINION ON BIOLOGICAL THERAPY, vol. 7, no. 11, 1 November 2007 (2007-11-01), pages 1705-1721, XP055007188, ISSN: 1471-2598, DOI: 10.1517/14712598.7.11.1705 (B1)

LINCH S N ET AL: "OX40 agonists and combination immunotherapy: Putting the pedal to the metal", FRONTIERS IN ONCOLOGY, FRONTIERS RESEARCH FOUNDATION, CH, vol. 5, 16 February 2015 (2015-02-16), pages 1-14, XP002760409, ISSN: 2234-943X, DOI: 10.3389/FONC.2015.00034 [retrieved on 2015-01-01] (B1)

MARIO P COLOMBO ET AL: "Interleukin-12 in anti-tumor immunity and immunotherapy", CYTOKINE AND GROWTH FACTOR REVIEWS, vol. 13, no. 2, 1 April 2002 (2002-04-01), pages 155-168, XP055389487, GB ISSN: 1359-6101, DOI: 10.1016/S1359-6101(01)00032-6 (B1)

P CHAROENSIT ET AL: "Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice", CANCER GENE THERAPY, vol. 17, no. 7, 23 April 2010 (2010-04-23) , pages 512-522, XP055388601, GB ISSN: 0929-1903, DOI: 10.1038/cgt.2010.12 (B1)

S TUGUES ET AL: "New insights into IL-12-mediated tumor suppression", CELL DEATH AND DIFFERENTIATION., vol. 22, no. 2, 5 September 2014 (2014-09-05), pages 237-246, XP055285716, GB ISSN: 1350-9047, DOI: 10.1038/cdd.2014.134 (B1)

SHIN FOONG NGIOW ET AL: "A balance of interleukin-12 and -23 in cancer", TRENDS IN IMMUNOLOGY, vol. 34, no. 11, 1 November 2013 (2013-11-01), pages 548-555, XP055401377, GB ISSN: 1471-4906, DOI: 10.1016/j.it.2013.07.004 (B1)

UGUR SAHIN ET AL: "mRNA-based therapeutics - developing a new class of drugs", NATURE REVIEWS DRUG DISCOVERY, vol. 13, no. 10, 19 September 2014 (2014-09-19), pages 759-780, XP055159205, ISSN: 1474-1776, DOI: 10.1038/nrd4278 (B1)

W. W. OVERWIJK ET AL: "Immunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant", THE JOURNAL OF IMMUNOLOGY, vol. 176, no. 9, 1 May 2006 (2006-05-01), pages 5213-5222, XP055236716, US ISSN: 0022-1767, DOI: 10.4049/jimmunol.176.9.5213 (B1)

WANG J ET AL: "Synergistic anti-tumor effect by combinatorial gene-gun therapy using IL-23 and IL-18 cDNA", JOURNAL OF DERMATOLOGICAL SCI, ELSEVIER, AMSTERDAM, NL, vol. 36, no. 1, 1 October 2004 (2004-10-01), pages 66-68, XP004603021, ISSN: 0923-1811, DOI: 10.1016/J.JDERMSCI.2004.08.001 (B1)

WANG XUEFENG ET AL: "IL-36[gamma] Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Respo", CANCER CELL, vol. 28, no. 3, 14 September 2015 (2015-09-14), pages 296-306, XP029268946, ISSN: 1535-6108, DOI: 10.1016/J.CCELL.2015.07.014 (B1)

HARA I ET AL: "Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration", CANCER GENE THERAPY, APPLETON & LANGE, GB, vol. 7, no. 1, 1 January 2000 (2000-01-01) , pages 83-90, XP002533119, ISSN: 0929-1903, DOI: 10.1038/SJ.CGT.7700083 (B1)